Mind Medicine (MNMD) Misses Q2 EPS by 13c

Mind Medicine (NASDAQ: MNMD) reported Q2 EPS of ($0.50), $0.13 worse than the analyst estimate of ($0.37).

For earnings history and earnings-related data on Mind Medicine (MNMD) click here.

You May Also Be Interested In

• Blue Owl leads $2.4 billion debt deal for Iren data center
• Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
• BW LPG Limited (BWLP) Reports Q1 EPS of $0.79